Sign In
Get Clay Free →

Suggestions

    Doron Greenbaum Ph.D.

    Private Biotech Investment Firm

    Doron Greenbaum is an accomplished executive with extensive experience in external innovation, business development, and start-up management. He has a Ph.D. in Chemical Biology from the University of California, San Francisco, and a Bachelor's degree in Biology/Biological Sciences, and Chemistry from Williams College. Greenbaum also has over 40 publications to his name in various scientific areas such as gene therapy, biologicals, biochemistry, as well as therapeutic experience in neuroscience, fibrosis, oncology and emerging infectious diseases.

    Greenbaum's impressive career has included roles such as Director of Drug Discovery Technologies and External Innovation at Biogen, Professor and Director of Research Operations at the Pennsylvania Drug Discovery Institute, CEO of Phelix Therapeutics LLC, and Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania.

    Overall, Greenbaum's expertise in chemical biology and drug discovery, along with his strong business acumen, make him a valuable asset to any organization looking to innovate and grow in the biotech industry.

    Highlights

    Pulmonary Fibrosis Therapy Creator Phelix Gets $201,000 NIH Grant - Pulmonary Fibrosis News

    Related Questions

    What are Doron Greenbaum's key achievements at Biogen?
    How did Doron Greenbaum transition from Phelix Therapeutics to Biogen?
    What specific technologies does Doron Greenbaum oversee at Biogen?
    Can you provide examples of Doron Greenbaum's work in drug discovery?
    What is Doron Greenbaum's educational background?
    Doron Greenbaum Ph.D.
    Doron Greenbaum Ph.D., photo 1
    Doron Greenbaum Ph.D., photo 2
    Get intro to Doron
    Add to my network

    Location

    Philadelphia, Pennsylvania, United States